Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 5/20 | 0.35 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | RAD52 | P43351 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17381611 | 1.00 | NR1H4 (0.35) | NR1H4PDE7APDE3APDE10AALDH1A1 | |
| SCHEMBL31236970 | 0.92 | RAD52 (0.32) | PDE7APDE3APDE10AALDH1A1RAD52 | |
| SCHEMBL17385321 | 0.92 | CCNA2 (0.39) | NR1H4ALDH1A1 | |
| SCHEMBL20988684 | 0.91 | NR1H4 (0.35) | NR1H4PDE7APDE3APDE10AALDH1A1 | |
| SCHEMBL17381600 | 0.90 | NR1H4 (0.35) | NR1H4PDE7APDE3APDE10A | |
| SCHEMBL24758668 | 0.90 | NR1H4 (0.36) | NR1H4PDE7APDE3APDE10ARAD52 | |
| SCHEMBL19305847 | 0.88 | NR1H4 (0.34) | NR1H4PDE7APDE3APDE10A | |
| SCHEMBL17381962 | 0.87 | NR1H4 (0.38) | NR1H4 | |
| SCHEMBL29539301 | 0.86 | PDE7A (0.32) | NR1H4PDE7APDE3APDE10A | |
| SCHEMBL16334006 | 0.86 | PDE7A (0.32) | NR1H4PDE7APDE3APDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598928-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | Radionetics Oncology, Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| WO-2024077006-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2024-04-11 | — | — | WO | disclosed |